Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Pain, Postoperative 9Pain 5Neuralgia 5Breast Neoplasms 5Agnosia 4Neoplasms 3Head and Neck Neoplasms 2Chronic Pain 2Visceral Pain 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Seizures 1Pinealoma 1Persistent Postoperative Pain 1Pancreatic Neoplasms 1Pain, Intractable 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Myotoxicity 1Mouth Neoplasms 1Meningioma 1Medulloblastoma 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Leiomyoma 1Inflammation 1Hot Flashes 1

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma × Pregabalin × Clear all
NCT03407430 2018-06-26

Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
11 enrolled 17 charts
BreastLymphoid

Breast Neoplasms, Lymphoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡